Valuation Zenotech Laboratories Limited

Stocks

Market Closed - Bombay S.E. 06:26:03 2026-09-10 EDT			5-day change	1st Jan Change
44.67 ^INR	-1.59%		-2.62%	-3.29%

07-28	Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
04-29	Zenotech Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Market Cap ¹	2,136	3,073	2,872	3,608	3,169	2,093
Change	-	43.86%	-6.53%	25.61%	-12.16%	-33.96%
Enterprise Value (EV) ¹	2,318	3,109	2,761	3,411	2,902	1,788
Change	-	34.11%	-11.2%	23.54%	-14.92%	-38.36%
P/E	-175x	13.9x	24.8x	43.5x	56.5x	-191x
PBR	4.41x	4.35x	3.49x	3.98x	3.3x	2.2x
PEG	-	-0x	-0.5x	-1.5x	-1.7x	2x
Capitalization / Revenue	11x	9.33x	7.36x	9.8x	8.1x	5.21x
EV / Revenue	12x	9.44x	7.08x	9.27x	7.42x	4.45x
EV / EBITDA	36.3x	17.4x	12.9x	19.8x	20.3x	18.1x
EV / EBIT	-3,050x	28.4x	19.5x	33.5x	39.4x	64.9x
EV / FCF	-148x	26.6x	26x	71.4x	73.4x	-132x
FCF Yield	-0.68%	3.75%	3.84%	1.4%	1.36%	-0.76%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-0.2	3.63	1.898	1.36	0.9197	-0.18
Distribution rate	-	-	-	-	-	-
Net sales ¹	193.7	329.5	390.1	368.1	391	401.6
EBITDA ¹	63.8	179.2	213.6	172.6	143.2	98.69
EBIT ¹	-0.76	109.4	141.9	101.8	73.6	27.56
Net income ¹	-12.15	221.8	115.9	82.99	56.13	-10.72
Net Debt ¹	182	35.85	-111.4	-196.9	-267	-304.2
Reference price ²	35.00	50.35	47.06	59.11	51.92	34.29
Nbr of stocks (in thousands)	61,031	61,031	61,031	61,031	61,031	61,031
Announcement Date	9/2/21	8/30/22	9/5/23	9/2/24	9/1/25	8/28/26

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ZENOTECH LABORATORIES LIMITED	-	-	-	-	29.11M
ELI LILLY AND COMPANY	32x	11.63x	23.59x	0.62%	1,002B
JOHNSON & JOHNSON	28.37x	6.53x	17.91x	2.01%	644B
ABBVIE INC.	32.13x	7.46x	15.49x	2.73%	443B
ROCHE HOLDING AG	18.9x	4.61x	11.42x	2.88%	343B
NOVARTIS AG	19.46x	5.11x	12.69x	3.2%	262B
ASTRAZENECA PLC	20.29x	4.17x	11.93x	2.12%	245B
AMGEN INC.	24.75x	6.5x	11.57x	2.58%	212B
NOVO NORDISK A/S	12.86x	4.67x	9.75x	3.91%	199B
GILEAD SCIENCES, INC.	-44.5x	6.43x	25.11x	2.26%	181B
Average	16.03x	6.35x	15.50x	2.48%	352.97B
Weighted average by Cap.	22.91x	7.53x	17.31x	2.04%